20.04.2013 • NewsSinopecChinaearthquake

China's Sinopec Says No Impact On Gas Field From Quake

Sinopec Group, Asia's largest oil refiner, said its huge Puguang gas field in southwest China's Sichuan province had not been affected by a strong earthquake that struck the region on Saturday.

Spokesman Lv Dapeng said a pipeline that supplies gas from the field, one of China's largest, to the city of Shanghai was also functioning normally, as were its service stations in the region.

The company had prepared reserves of fuel to help with relief efforts, Lv said.

Sichuan is one of the four major natural-gas-producing provinces in China, and its output accounts for about 14% of the nation's total.

China's top oil company, PetroChina, which also has oil and gas production facilities in the province, could not immediately be reached for comment.

The firm has said that it plans to start a trial run of its 200,000 barrels-per-day Pengzhou refinery in Sichuan this month.

Construction of the plant, the largest refining and chemical complex in southwestern China, was briefly halted in 2008 after an earthquake that killed some 70,000.

On Saturday, a 6.6 magnitude earthquake hit the province killing at least 28 people and injuring at least 100.

 

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.